Immune Thrombocytopenia — Microlearning Activity 4 with Dr Hanny Al-Samkari: ASH 2025 Review
Dr Hanny Al-Samkari from Massachusetts General Hospital in Boston discusses recent developments from the ASH 2025 Annual Meeting involving the use of Bruton tyrosine kinase inhibitors and BAFF-R antagonists in the treatment of immune thrombocytopenia.
CME information and select publications here.
You May Also Like
Bigfoot Eyewitness Radio
Vic Cundiff
Real Ghost Stories Online
Real Ghost Stories Online | Paranormal, Supernatural & Horror Radio
The Dissenter
Ricardo Lopes
This Week in Cardiology
Medscape
Life, Death, and Taxonomy
Life, Death, and Taxonomy
Accès au Marché Mondial des Dispositifs Médicaux
Pure Global
Vida Eterna. Respuestas desde la Ciencia | Dr. Manuel Sans Segarra
Dr. Manuel Sans Segarra
The Best of Coast to Coast AM
iHeartPodcasts and Coast to Coast AM
Eye On The Sky
Vermont Public
UAP Files Podcast
UAP Files Podcast
Bigfoot Eyewitness Radio
Vic Cundiff
Real Ghost Stories Online
Real Ghost Stories Online | Paranormal, Supernatural & Horror Radio
The Dissenter
Ricardo Lopes
This Week in Cardiology
Medscape
Life, Death, and Taxonomy
Life, Death, and Taxonomy
Accès au Marché Mondial des Dispositifs Médicaux
Pure Global
Vida Eterna. Respuestas desde la Ciencia | Dr. Manuel Sans Segarra
Dr. Manuel Sans Segarra
The Best of Coast to Coast AM
iHeartPodcasts and Coast to Coast AM
Eye On The Sky
Vermont Public
UAP Files Podcast
UAP Files Podcast
Community discussion